177 related articles for article (PubMed ID: 35202617)
1. Cellular variant of kaposiform lymphangiomatosis: a report of three cases, expanding the morphologic and molecular genetic spectrum of this rare entity.
Allen-Rhoades W; Al-Ibraheemi A; Kohorst M; Tollefson M; Hull N; Polites S; Folpe AL
Hum Pathol; 2022 Apr; 122():72-81. PubMed ID: 35202617
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
Ji Y; Chen S; Peng S; Xia C; Li L
Orphanet J Rare Dis; 2019 Jul; 14(1):165. PubMed ID: 31277673
[TBL] [Abstract][Full Text] [Related]
3. Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly.
Croteau SE; Kozakewich HP; Perez-Atayde AR; Fishman SJ; Alomari AI; Chaudry G; Mulliken JB; Trenor CC
J Pediatr; 2014 Feb; 164(2):383-8. PubMed ID: 24252784
[TBL] [Abstract][Full Text] [Related]
4. Proliferative Cells From Kaposiform Lymphangiomatosis Lesions Resemble Mesenchyme Stem Cell-like Pericytes Defective in Vessel Formation.
Glaser K; Dickie P; Dickie BH
J Pediatr Hematol Oncol; 2018 Nov; 40(8):e495-e504. PubMed ID: 30256265
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis.
Boscolo E; Pastura P; Glaser K; Goines J; Hammill AM; Adams DM; Dickie P; Hsi Dickie B; Le Cras TD
Pediatr Blood Cancer; 2019 Aug; 66(8):e27790. PubMed ID: 31045327
[TBL] [Abstract][Full Text] [Related]
6. Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder.
Fernandes VM; Fargo JH; Saini S; Guerrera MF; Marcus L; Luchtman-Jones L; Adams D; Meier ER
Pediatr Blood Cancer; 2015 May; 62(5):901-4. PubMed ID: 25307772
[TBL] [Abstract][Full Text] [Related]
7. [Role of master transcriptional factor Prox-1 in lymphatic endothelial differentiation of Kaposiform hemangioendothelioma].
Ke ZY; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):176-181. PubMed ID: 28297758
[No Abstract] [Full Text] [Related]
8. Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin-2 levels.
Crane J; Manfredo J; Boscolo E; Coyan M; Takemoto C; Itkin M; Adams DM; Le Cras TD
Pediatr Blood Cancer; 2020 Sep; 67(9):e28529. PubMed ID: 32634277
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
[TBL] [Abstract][Full Text] [Related]
10. Imaging features of kaposiform lymphangiomatosis.
Goyal P; Alomari AI; Kozakewich HP; Trenor CC; Perez-Atayde AR; Fishman SJ; Greene AK; Shaikh R; Chaudry G
Pediatr Radiol; 2016 Aug; 46(9):1282-90. PubMed ID: 27053281
[TBL] [Abstract][Full Text] [Related]
11. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis.
Zukerberg LR; Nickoloff BJ; Weiss SW
Am J Surg Pathol; 1993 Apr; 17(4):321-8. PubMed ID: 8494101
[TBL] [Abstract][Full Text] [Related]
12. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.
Putra J; Gupta A
Pathology; 2017 Jun; 49(4):356-362. PubMed ID: 28438388
[TBL] [Abstract][Full Text] [Related]
13. Kaposiform hemangioendothelioma and tufted angioma - (epi)genetic analysis including genome-wide methylation profiling.
Ten Broek RW; Koelsche C; Eijkelenboom A; Mentzel T; Creytens D; Vokuhl C; van Gorp JM; Versleijen-Jonkers YM; van der Vleuten CJ; Kemmeren P; van de Geer E; von Deimling A; Flucke U
Ann Diagn Pathol; 2020 Feb; 44():151434. PubMed ID: 31887709
[TBL] [Abstract][Full Text] [Related]
14. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.
Lyons LL; North PE; Mac-Moune Lai F; Stoler MH; Folpe AL; Weiss SW
Am J Surg Pathol; 2004 May; 28(5):559-68. PubMed ID: 15105642
[TBL] [Abstract][Full Text] [Related]
15. Atypically presenting kaposiform hemangioendothelioma of the knee: ultrasound findings.
Erdem Toslak I; Stegman M; Reiter MP; Barkan GA; Borys D; Lim-Dunham JE
J Med Ultrason (2001); 2018 Oct; 45(4):653-656. PubMed ID: 29637402
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of Kaposiform hemangioendothelioma.
Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietins as serum biomarkers for lymphatic anomalies.
Le Cras TD; Mobberley-Schuman PS; Broering M; Fei L; Trenor CC; Adams DM
Angiogenesis; 2017 Feb; 20(1):163-173. PubMed ID: 27990590
[TBL] [Abstract][Full Text] [Related]
19. Kaposiform Hemangioendothelioma: clinicopathological characteristics of 8 cases of a rare vascular tumor and review of literature.
Chundriger Q; Tariq MU; Abdul-Ghafar J; Ahmed A; Din NU
Diagn Pathol; 2021 Mar; 16(1):23. PubMed ID: 33722245
[TBL] [Abstract][Full Text] [Related]
20. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
